Clinical Trial Update: Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in metastatic melanoma evaluating radiation, chemotherapy, a melanoma vaccine, and anti-MART-1 and anti-GP100 cell therapies; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Skin Cancer

Drugs mentioned

• Anti-MART-1 cells (anti-MART-1 cell therapy)
• Anti-gp100 Cells

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma, Skin Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-11-05